Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

22.40USD
8:00pm GMT
Change (% chg)

$-1.06 (-4.52%)
Prev Close
$23.46
Open
$23.00
Day's High
$23.29
Day's Low
$22.12
Volume
323,378
Avg. Vol
235,000
52-wk High
$36.12
52-wk Low
$21.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -0.953
Sep '18 0.00 -0.887
Jun '18 0.00 -0.908
Mar '18 0.00 -0.924
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 10 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 10 0.00 0.00 0.00 0.00
Year Ending Dec-19 11 4.34 37.73 0.00 36.92
Year Ending Dec-20 9 101.12 231.65 42.10 238.12
Earnings (per share)
Quarter Ending Mar-19 11 -0.97 -0.88 -1.01 -0.75
Quarter Ending Jun-19 11 -0.99 -0.90 -1.15 -0.77
Year Ending Dec-19 11 -4.04 -3.63 -4.72 -2.56
Year Ending Dec-20 9 -2.81 -1.37 -4.44 0.88
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.54
P/E High - Last 5 Yrs. -- 43.23 48.15
P/E Low - Last 5 Yrs. -- 22.71 23.42
Beta -- 0.86 0.87
Price to Sales (TTM) -- 6.59 8.39
Price to Book (MRQ) 5.40 5.12 5.27
Price to Tangible Book (MRQ) 5.41 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions 85.47 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 3.99 4.70
Payout Ratio(TTM) -- 42.18 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 6.61 8.02
Sales - 5 Yr. Growth Rate -- 10.48 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 45.67 47.68
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.47
Capital Spending - 5 Yr. Growth Rate -- 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 13.45 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.87 11.35
Total Debt to Equity (MRQ) 0.00 12.87 16.02
Interest Coverage (TTM) -- 32.47 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.10 52.41
Gross Margin - 5 Yr. Avg. -- 49.66 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.26 12.43
Operating Margin (TTM) -- 13.53 5.77
Operating Margin - 5 Yr. Avg. -- 13.69 8.02
Pre-Tax Margin (TTM) -- 11.90 4.80
Pre-Tax Margin - 5 Yr. Avg. -- 14.10 8.31
Net Profit Margin (TTM) -- 8.81 1.53
Net Profit Margin - 5 Yr. Avg. -- 10.59 4.72
Effective Tax Rate (TTM) -- 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 928,328,965 820,341,642
Net Income/Employee (TTM) -1,529,406 105,131,996 92,858,478
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 10.98 10.60
Return on Assets - 5 Yr. Avg. -- 12.41 11.78
Return on Investment (TTM) -50.47 14.23 13.82
Return on Investment - 5 Yr. Avg. -- 16.18 15.32
Return on Equity (TTM) -50.82 15.46 15.25
Return on Equity - 5 Yr. Avg. -- 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 99 31
13 Week 22.10 16.15 99 42
26 Week 26.67 17.04 99 45
52 Week 53.60 30.19 99 9
YTD 24.01 8.91 99 37
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.42%
# of Holders: 186
Total Shares Held: 51,878,039
3 Mo. Net Change: 1,904,746
# New Positions: 25
# Closed Positions: 39
# Increased Positions: 91
# Reduced Positions: 89
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.